A carregar cotações...
Previsão
Não temos dados de analistas para esta empresa.
Notícias Ir para o feed de notícias
Asker Healthcare Group Registered increases revenue by 17.5% to SEK 4.69bn, earnings per share SEK 0.57
For the quarter to 30.06.2026, Asker Healthcare Group Registered reports revenue of SEK 4.69 billion, up 17.53% year on year. Earnings per share were SEK 0.57 (prior year SEK 0.34). Analysts had expected SEK 0.63 per share and revenue of SEK 4.68 billion, so revenue was roughly in line while earnings slightly missed the estimate. » Mais em finanzen.net
Asker Healthcare Group Registered announces quarterly results for end of June, analysts expect earnings and revenue growth
Asker Healthcare Group Registered will present results for the quarter ended 30 June 2026 on 21 July 2026. Three analysts expect an average EPS of 0.660 SEK per share (prior year 0.340 SEK). Five analysts forecast revenue of an average 4.66 billion SEK, up 16.78% from the year-ago quarter. For the current fiscal year, six analysts on average project an EPS of 2.83 SEK and revenue of 19.06 billion SEK, compared with 1.25 SEK and 16.79 billion SEK in the prior year. » Mais em finanzen.net
Asker Healthcare Group Registered: analysts expect significantly higher quarterly results
Asker Healthcare Group Registered will open the books on 21 July 2026 for the quarter ended 30 June 2026. Three analysts estimate EPS on average at 0.660 SEK (previous year 0.340 SEK). Five analysts expect revenue of an average 4.65 billion SEK, an increase of 16.69% compared with 3.99 billion SEK in the previous year. For the fiscal year, consensus estimates are 2.83 SEK earnings per share and revenue of 19.09 billion SEK (previous year 1.25 SEK and 16.79 billion SEK). » Mais em finanzen.net
Dividendos históricos Dividendos
Todos os indicadores de dividendos Todos os indicadoresDados financeiros da empresa
| (EUR) | junho de 2026 | |
|---|---|---|
| Receitas | 422,85 mi | 18,17% |
| Ganho bruto | 177,41 mi | 21,27% |
| Ganho líquido | 19,76 mi | 70,70% |
| EBITDA | 54,5 mi | 143,90% |
Dados fundamentais
| Métrica | Valor |
|---|---|
Capitalização bolsista | € 2,45 bi |
Número de ações | 383,04 mi |
Máximo/mínimo de 52 semanas | € 8,62 - € 5,21 |
Rentabilidade de dividendos | 0,67% |
Dividendos TTM | € 0,0355 |
Beta | -1,06 |
PER (PE Ratio) | 40,39 |
PEG (PEG Ratio) | 0,28 |
P/VC (PB Ratio) | 3,95 |
P/V (PS Ratio) | 1,53 |
Perfil da empresa
| Nome | Asker Healthcare Group |
| CEO | Johan Falk |
| Colaboradores | 4.885 |
Símbolos de ticker
| Bolsa | Símbolo |
|---|---|
Düsseldorf | I88.DU |